About Garuda TX
Garuda TX is a Healthcare company based in Natick (United States) founded in 2021 by David Scadden and Sean Morrison. Stem cell therapies are developed for treating multiple diseases. Garuda TX has raised $181.83 million across 3 funding rounds from investors including ARE, Resilience and Orbimed. The company has 53 employees. Its focus areas include Life Sciences, Transplant Medicine, Drugs and Cell Therapy. Its legal entity is GARUDA THERAPEUTICS, INC. Its competitors include Biogen, CareDx and ADMA Biologics; 3 of its 3 listed competitors have raised funding.
Company details
Stem cell-based therapies are developed by Garuda, founded in 2021 and based in Natick, United States, within the biotechnology sector. Operations focus on stem cell transplants enhanced by targeted antibodies and self-renewal pathway modulation to increase cell numbers. The pipeline addresses hematologic malignancies, sickle cell disease, β-thalassemia, bone marrow failure conditions, and additional indications. Co-founders include David Scadden and Sean Morrison.
- Headquarters Natick, United States
- Employees 53
- Founders David Scadden, Sean Morrison
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website garudatx.com
- Social LinkedIn
- Legal Name Garuda Therapeutics, Inc
- Total Equity Funding$181.83M (USD)
in 3 rounds
- Latest Funding Round$47.71M (USD), Series B
Oct 2024
- InvestorsARE
& 10 more
- Employee Count53
Funding Insights of Garuda TX
Garuda TX has successfully raised a total of $181.83M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $47.71 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $181.83M
- Total Rounds 3
- Last Round Series B β $47.71M
- First Round $72M
(Sep 2021)
- Investors Count 11
All 3 funding rounds of Garuda TX with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2024 | $47.71M | Series B | β | β | β |
| Feb 2023 | $62.12M | Series B | β | Northpond Ventures, Orbimed | |
| Sep 2021 | $72M | Series A | β | Aisling Capital, Northpond Ventures |
11 investors in total: 11 institutional.
Investors in Garuda TX
Garuda TX has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include ARE, Resilience and Orbimed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm investing in life sciences & tech sectors | npv.vc | Cambridge, United States | ||
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields. | 1989 | orbimed.com | New York, United States | |
PE firm investing in the US | aislingcapital.com | New York, United States | ||
Sectoral Asset Management is focused on global healthcare investment. | 2000 | sectoral.com | Montreal, Canada | |
Ridgeback Capital is focused on healthcare and life science investments. | ridgebackcap.com | New York, United States | ||
| massgeneralbrighamventures.com | ||||
Manages diversified investment portfolios across various asset classes. | 1997 | cormorant.com | Boston, United States | |
| partners.org | ||||
REIT that invests in campuses, multi-tenant spaces and build-to-suit facilities in the US | 1994 | are.com | Pasadena, United States | |
Diversified investment management services are provided to clients. | 2011 | monasheecap.com | Boston, United States |
Investor details for Garuda TX
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Garuda TX
37 people are tracked at Garuda TX (15 in leadership, 12 in board & advisors, 10 in team); the tracked headcount is 53.
| Name | Role | Group |
|---|---|---|
David Scadden | Co-Founder | Leadership |
Sean Morrison | Co-Founder | Leadership |
Adam R. Craig | CEO | Leadership |
Albert Paszek | Vice President, Manufacturing | Leadership |
David H. Kirske | CFO | Leadership |
Tom Crean | Vice President Regulatory Affairs-CMC | Leadership |
Rossana Serpe, Ph.D. | Associate Director Of Research And Development | Leadership |
Ana Castano. M.D. | Associate Director | Leadership |
David DiGiusto | Chief Technology Officer | Leadership |
Gurinder Singh | Associate Director | Leadership |
Shannon Leonard | Director Of Project Management | Leadership |
Yusef Yacoubaissa | Vice President, Quality Assurance | Leadership |
Luis Escobar | Associate Director Quality Assurance | Leadership |
Giuliana Medrano | Sr. Director, Quality Control Lead - Cgmp, Cell Therapies | Leadership |
Hua Deng | Executive Director Program Management | Leadership |
Rahul Singhvi | Director | Board & advisors |
John E. Wagner | Scientific Advisor | Board & advisors |
Jerome Ritz | Scientific Advisor | Board & advisors |
Marcel Van Den Brink | Scientific Advisor | Board & advisors |
Carl Gordon | Director | Board & advisors |
17 more people are available in the full profile.
Complete people profiles for Garuda TX
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Garuda TX
3 dated milestones of Garuda TX across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Garuda TX is founded.
- Funding First funding round of $72.0M.
- Funding Latest funding round, Series B, of $47.7M.
Competitors of Garuda TX
Garuda TX has 3 listed competitors in our database, 3 of them funded. They include Biogen, CareDx and ADMA Biologics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biogen.com | 1978 | Cambridge, United States | $80M | 1 | Therapies for neurodegenerative and immunology disorders are developed. | |
| caredx.com | 1998 | Brisbane, United States | $138.21M | 645 | Medical solutions for transplant patients are developed and provided. | |
| admabiologics.com | 2005 | Ramsey, United States | $17.55M | 498 | Plasma-based biologics are developed for immune deficiency and infectious diseases. |
Detailed competitors of Garuda TX
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Transplant Medicine
3 companies that operate in the same segment as Garuda TX (Transplant Medicine) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medical solutions for transplant patients are developed and provided. | 1998 | Brisbane, California, United States | USD 138.21 M | USD 379.81 M | 650 | |
Developer of organ transplantation technology | 1998 | Andover, Massachusetts, United States | USD 265.55 M | USD 605.49 M | 728 | |
Human tissue-based products are developed for vascular disease applications. | 2004 | Morrisville, United States | USD 424.76 M | USD 2.04 M | 220 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Garuda Tx
Complete news archive for Garuda TX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Garuda TX
Garuda TX was founded in 2021.
Garuda TX is headquartered in Natick, United States. It is registered at Natick, Massachusetts, United States.
Garuda TX is a funded company, having raised a total of $181.83M across 3 funding rounds to date. The company's 1st funding round was a Series A of $72M, raised on Sep 2021.
Garuda TX has 53 employees.
Stem cell-based therapies are developed by Garuda, founded in 2021 and based in Natick, United States, within the biotechnology sector. Operations focus on stem cell transplants enhanced by targeted antibodies and self-renewal pathway modulation to increase cell numbers. The pipeline addresses hematologic malignancies, sickle cell disease, Ξ²-thalassemia, bone marrow failure conditions, and additional indications. Co-founders include David Scadden and Sean Morrison.
Garuda TX's top competitors include CareDx, ADMA Biologics and Biogen.
Garuda TX has 11 investors. Key investors include ARE, Resilience, Orbimed, Monashee Investment Management, and Northpond Ventures.
Garuda TX operates through Garuda Therapeutics, Inc.